VIRTUAL DIALOGUE METHOD FOR PATIENT EDUCATION

妇女需要了解有关乳腺癌的基本信息，以及保健提供者对患者进行疾病教育的时间有限，这些都是本提案所要解决的问题。在第一阶段，IDI制作并实地测试了三个声控程序，使患有或没有乳腺癌的妇女能够与肿瘤学家、执业护士和乳腺癌幸存者进行“面对面”的虚拟对话。研究结果表明，通过这种方法，在乳房自我检查、风险因素、风险降低、早期检测、诊断程序和治疗方面取得了显著的学习成果。此外，受试者报告说，他们对与卫生专业人员沟通的能力信心增强，并从虚拟对话中获得了明显的情感支持。在第二阶段，IDI将加强和扩大乳腺癌患者教育系列，并具体评估虚拟对话方法加强患者和医疗保健提供者之间沟通的能力。将开发另外五个项目，包括更多的乳腺癌专家和幸存者的观点。这些项目将在乔治敦大学的隆巴迪癌症中心和乔治梅森大学的三个校区进行实地测试，测试对象是不同年龄、种族和社会经济背景的女性。拟议的商业应用：这种独特的产品将提供给乳房健康诊所、妇女健康中心、医院、健康维护组织（HMOs）、首选提供者组织（PPOs）、私人诊所和社区诊所。

Women's need for basic information about breast cancer, and the constraints on the time that health care providers have to educate their patients about the disease, are issues addressed in this proposal. In Phase I, IDI produced and field tested three voice-activated programs that allow women with and without breast cancer to engage in "face-to- face" virtual dialogues with an oncologist, a nurse practitioner, and a breast cancer survivor. The research findings showed that significant learning gain concerning breast self-exam, risk factors, risk reduction, early detection, diagnostic procedures, and treatment occurred with this method, Also, subjects reported increased feelings of confidence regarding their ability to communicate with health professionals and distinct feelings of emotional support from their virtual dialogues. In Phase II, IDI will enhance and expand the Patient Education on Breast Cancer Series and specifically evaluate the capability of the virtual dialogue method to enhance communication between patients and health care providers. Five additional programs will be developed to include additional breast cancer experts and survivor perspectives. The programs will be field tested at the Lombardi Cancer Center of Georgetown University and on three campuses of George Mason University by female subjects of diverse ages, ethnicity, and socioeconomic backgrounds. PROPOSED COMMERCIAL APPLICATION: This unique product will be made available to breast health clinics, women's health centers, hospitals, health maintenance organizations (HMOs), preferred provider organizations (PPOs), private practices, and community clinics.